Symbol | Exchange | Currency |
|---|
Feb 10 (Reuters) - Wellfully Ltd WFL.AX :* PLACEMENT, LOYALTY OFFER AND UMP SALE FACILITY-WFL.AX* PLACEMENT WILL COMPRISE OF A MAXIMUM ISSUE OF UP TO 63.3 MILLION SHARES AT...
Dec 21 (Reuters) - Wellfully Ltd WFL.AX :* WILL COLLABORATE WITH NSW-BASED DOLCE CANN GLOBAL TO DEVELOP CANNABINOID PRODUCTS USING ITS PATENTED DRUG DELIVERY SYSTEM
Dec 10 (Reuters) - Wellfully Ltd WFL.AX :* P&G GRANTS NON EXCLUSIVE LICENSE* COMPLETED TALKS WITH P&G TO ALLOW CO TO USE ITS MAGNETIC MICROARRAY, POWERED ARRAY TECH IN ITS OWN...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 17.93 | 18.02 | 17.53 | -0.03 | -0.17% | 2.27M | Sydney | |||
| 0.29 | 0.00 | 0.00 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 31.31 | 31.54 | 30.88 | +0.08 | +0.26% | 227.24K | Sydney | |||
| 3.48 | 3.555 | 3.47 | -0.090 | -2.52% | 1.48M | Sydney | |||
| 0.001 | 0.00 | 0.00 | 0.000 | 0.00% | 3.51M | Sydney | |||
| 0.125 | 0.00 | 0.00 | 0.000 | 0.00% | 6.38K | Sydney | |||
| 0.014 | 0.00 | 0.00 | -0.001 | -6.67% | 193.30K | Sydney | |||
| 0.195 | 0.00 | 0.00 | -0.015 | -7.14% | 134.16K | Sydney | |||
| 0.845 | 0.00 | 0.00 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 0.087 | 0.00 | 0.00 | -0.003 | -3.33% | 204.00K | Sydney | |||
| 0.006 | 0.00 | 0.00 | -0.002 | -25.00% | 101.19M | Sydney | |||
| 0.12 | 0.00 | 0.00 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 1.03 | 1.063 | 0.00 | +0.010 | +0.98% | 169.27M | Sydney | |||
| 0.066 | 0.00 | 0.00 | 0.000 | 0.00% | 146.00K | Sydney | |||
| 0.17 | 0.00 | 0.00 | +0.005 | +3.03% | 437.12K | Sydney |
Wellfully Limited, formerly OBJ Limited, is engaged in the research and development of its dermaportation and estrogen transdermal patch (ETP) transdermal drug delivery technologies. It develops magnetic, micro-array drug and ingredient delivery technologies. It provides partnering services and product solutions for technologies in transdermal and intra-dermal drug delivery; therapeutic and dermatological skincare; cosmetic and non-medicinal active ingredient with a special focus on anti-aging and peptide delivery; oral health strips, toothbrush technologies and mouthguards; haircare solutions utilizing brushes and applicators; industrial surface interface systems; fabric and carpet cleaning technologies, and surface hygiene technologies. It operates skin labs and provides in-vivo and ex-vivo formulation profiling, skin penetration and partitioning services, including in-vivo tape stripping, accumulation and flux analysis and ex-vivo full thickness diffusion and partitioning.